Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: A model of sodium channel myotonia

Neuromuscular Disorders

Volumn 9, Issue 3, 1999, Pages 182-189

  Desaphy, J F ^a   Camerino, D Conte ^a   Tortorella, V ^b   De Luca, A ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Facolta di Farmacia   (Italy)

Author keywords

ATX II; Mexiletine; Myotonia; Skeletal muscle; Sodium channel

Indexed keywords

MEXILETINE; SEA ANEMONE TOXIN; SODIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; MODEL; MUTATION; MYOTONIA; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SODIUM CURRENT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CNIDARIAN VENOMS; DISEASE MODELS, ANIMAL; MEMBRANE POTENTIALS; MEXILETINE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOTONIA; RATS; SODIUM CHANNELS;

EID: 0032765443     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00115-1     Document Type: Article

References (28)

1. Hille B. Ionic channels of excitable membranes. Sunderland, MA: Sinauer Associates Inc., 1984.
2. Cannon S.C. From mutation to myotonia in sodium channel disorders. Neuromusc Disord. 7:1997;241-249.
3. Hudson A.J., Ebers G.C., Bulman D.E. The skeletal muscle sodium and chloride channel diseases. Brain. 118:1995;547-563.
4. Lehmann-Horn F., Rüdel R. Hereditary non-dystrophic myotonias and periodic paralyses. Curr Opin Neurol. 8:1995;402-410.
5. Moxley III R.T. The myotonias: their diagnosis and treatment. Comprehen Ther. 22:1996;8-21.
6. + channels by antiarrhythmic drugs, neurotransmitters and hormones. Trends Pharmacol Sci. 13:1992;352-358.
7. + channels by local anesthetics. Science. 265:1994;1724-1728.
8. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 69:1977;497-515.
9. Hondeghem L.M., Katzung B.G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 472:1977;373-398.
10. Starmer C.F., Grant A.O., Strauss H.C. Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J. 46:1984;15-27.
11. + currents by mexiletine at the single channel level in guinea-pig ventricular myocytes. Br J Pharmacol. 110:1993;183-192.
12. + channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis. J Physiol. 466:1993;501-520.
13. Thomsen W.J., Catterall W.A. Localization of the receptor site for α-scorpion toxins by antibody mapping: implications for sodium channel topology. Proc Natl Acad Sci USA. 86:1989;10161-10165.
14. + channel alpha subunit. J Biol Chem. 271:1996;15950-15962.
15. Catterall W.A. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells by antiarrhythmic drugs. Mol Pharmacol. 20:1981;356-362.
16. Desaphy J.-F., De Luca A., Imbrici P., Conte Camerino D. Modification by ageing of the tetrodotoxin-sensitive sodium channels in rat skeletal muscle fibres. Biochim Biophys Acta. 1373:1998;37-46.
17. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
18. Desaphy J-F, De Luca A, Conte Camerino D. Blockade by cyclic AMP of native sodium channels of adult rat skeletal muscle fibers. Am J Physiol (Cell Physiol) 1989;275:C1465-1472C.
19. Colquhoun D, Sigworth FJ. Fitting and statistical analysis of single-channel records. In: Sakmann B, Neher E, editors. Single-Channel Recording. New York: Plenum Press, 1983:191-263.
20. Franchini C., Celluci C., Corso F., Lentini G., Scilimati A., Tortorella V., Stasi F. Stereospecific synthesis and absolute configuration of mexiletine. Chirality. 6:1994;590-595.
21. Chahine M., Plante E., Kallen R.G. Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel alpha-subunit expressed in tsA201 cells. J Membr Biol. 152:1996;39-48.
22. Cannon S.C., Strittmatter S.M. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron. 10:1993;317-326.
23. + channel mutation causing hyperkalemic periodic paralysis. Neuron. 10:1993;667-678.
24. De Luca A., Natuzzi F., Lentini G., Franchini C., Tortorella V., Conte Camerino D. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers. Naunyn-Schmiedeberg's Arch Pharmacol. 352:1995;653-661.
25. De Luca A., Natuzzi F., Falcone G., Duranti A., Lentini G., Franchini C., Tortorella V., Conte Camerino D. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide. Naunyn-Schmiedeberg's Arch Pharmacol. 356:1997;777-787.
26. + channels. Circ Res. 79:1996;103-108.
27. + channels. Am J Physiol. 274:1998;H477-H487.
28. De Luca A., Pierno S., Natuzzi F., Franchini C., Duranti A., Lentini G., Tortorella V., Jockusch H., Conte Camerino D. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse. J Pharmacol Exp Ther. 282:1997;93-100.